FDA approves groundbreaking fecal transplant pill for gut health.

The FDA has approved the first pill made from donated human feces, called Vowst, as a preventive treatment for recurrent infections with the bacterium Clostridioides difficile. The pill contains live bacteria and is taken orally, unlike the previously approved enema-based treatment. Antibiotics can disrupt the balance of bacteria in the gut, leading to C. diff infections. Fecal microbiota products offer a new way to prevent recurrent C. diff by replenishing the gut microbiome. The Vowst treatment regimen involves taking four capsules once a day for three days in a row, starting two to four days after finishing a course of antibiotics for C. diff.